Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 53: 489-497, 2007. First published January 26, 2007; 10.1373/clinchem.2006.078972
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow 078972.Supplemental Data
Right arrow All Versions of this Article:
clinchem.2006.078972v1
53/3/489    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haschke, M.
Right arrow Articles by Christians, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haschke, M.
Right arrow Articles by Christians, U.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Clinical Immunology
Right arrow Nutrition
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2007;53:489-497.)
© 2007 American Association for Clinical Chemistry, Inc.

Endocrinology and Metabolism

HPLC–Atmospheric Pressure Chemical Ionization MS/MS for Quantification of 15-F2t-Isoprostane in Human Urine and Plasma

Manuel Haschke1, Yan Ling Zhang1, Christine Kahle1, Jelena Klawitter1, Magdalena Korecka2, Leslie M. Shaw2 and Uwe Christians1,a

1 Clinical Research and Development, Department of Anesthesiology, University of Colorado Health Sciences Center, Denver, Colorado.
2 Department of Pathology and Laboratory Medicine, University of Pennsylvania Medical Center, Philadelphia, PA.

aAddress correspondence to this author at: Clinical Research and Development, Department of Anesthesiology, University of Colorado Health Sciences Center, 4200 East Ninth Ave., Room UH-2122, Campus Box B-113, Denver, Colorado 80262. Fax 303-315-1858; e-mail uwe.christians{at}uchsc.edu.

Background: Quantification of F2-Isoprostanes is considered a reliable index of the oxidative stress status in vivo and is valuable in the diagnosis and monitoring of a variety of diseases. Because of complex and lengthy sample preparation procedures, current chromatography/mass spectrometry and immunoassays are impractical for measuring larger numbers of samples. Thus, we developed and validated a semiautomated high-throughput HPLC tandem mass spectrometry assay for the quantification of F2-Isoprostane F2t in human urine and plasma.

Methods: After protein precipitation (500 µL methanol/zinc sulfate added to 500 µL plasma), samples were injected into the HPLC system and extracted online. The extracts were then back-flushed onto the analytical column and detected with an atmospheric pressure chemical ionization-triple quadrupole mass spectrometer monitoring the deprotonated molecular ions [M-H]– of 15-F2t-IsoP (m/z = 353->193) and the internal standard 15-F2t-IsoP-d4 (m/z = 357->197).

Results: In human urine, the assay was linear from 0.025 to 80 µg/L and in human plasma from 0.0025 to 80 µg/L (r2>0.99). Interday accuracy and precision for concentrations above the lower limit of quantification were <10%. Concentrations of 15-F2t-IsoP in urine of 16 healthy individuals ranged from 55–348 ng/g creatinine. In 16 plasma samples from healthy individuals, free 15-F2t-IsoP was detectable in all samples and concentrations were 3–25 ng/L.

Conclusions: Our assay meets all predefined method performance criteria, allows for analysis of >80 samples/day, and has sufficient sensitivity for quantifying 15-F2t-IsoP concentrations in plasma and urine from healthy individuals. It is, thus, suitable for clinical routine monitoring and the analysis of samples from larger clinical trials.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Association for Clinical Chemistry.